Clinical Study
Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona
Table 3
Interactions between tenofovir exposure and vitamin D deficiency with PTH levels.
| | Vitamin D < 12βng/ml | Vitamin D > 12βng/ml | | | | Tenofovir | No tenofovir | Tenofovir | No tenofovir | A versus B | A versus C | | (: 52) A | (: 33) B | (: 78) C | (: 65) D | | |
| PTH > 65βpg/mL | 31 (59.6%) | 11 (33.3%) | 33 (42.3%) | 11 (16.9%) | : 0.002 | : 0.07 | Median PTHβpg/mL (IQR) | 76 (52.5β105.5) | 47 (31.5β75) | 52 (35β90) | 40 (26β57) | : 0.001 | : 0.007 |
|
|